JP5688829B2 - 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット - Google Patents

示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット Download PDF

Info

Publication number
JP5688829B2
JP5688829B2 JP2007544210A JP2007544210A JP5688829B2 JP 5688829 B2 JP5688829 B2 JP 5688829B2 JP 2007544210 A JP2007544210 A JP 2007544210A JP 2007544210 A JP2007544210 A JP 2007544210A JP 5688829 B2 JP5688829 B2 JP 5688829B2
Authority
JP
Japan
Prior art keywords
transthyretin
substance
diabetes
marker substance
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007544210A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2007055341A1 (ja
Inventor
敏一 吉川
敏一 吉川
裕二 内藤
裕二 内藤
尚 有國
尚 有國
里美 赤桐
里美 赤桐
憲一 三原
憲一 三原
利哉 大木
利哉 大木
亜尚 山口
亜尚 山口
祥一 真船
祥一 真船
▲高▼橋　豊
豊 ▲高▼橋
由美子 中島
由美子 中島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMARKERSCIENCE CO., LTD
Original Assignee
BIOMARKERSCIENCE CO., LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOMARKERSCIENCE CO., LTD filed Critical BIOMARKERSCIENCE CO., LTD
Priority to JP2007544210A priority Critical patent/JP5688829B2/ja
Publication of JPWO2007055341A1 publication Critical patent/JPWO2007055341A1/ja
Application granted granted Critical
Publication of JP5688829B2 publication Critical patent/JP5688829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2007544210A 2005-11-11 2006-11-10 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット Active JP5688829B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007544210A JP5688829B2 (ja) 2005-11-11 2006-11-10 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2005327243 2005-11-11
JP2005327243 2005-11-11
JP2006187238 2006-07-06
JP2006187238 2006-07-06
PCT/JP2006/322506 WO2007055341A1 (fr) 2005-11-11 2006-11-10 Procede de pronostic/diagnostic differentiel du diabete et kit de pronostic/diagnostic du diabete
JP2007544210A JP5688829B2 (ja) 2005-11-11 2006-11-10 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット

Publications (2)

Publication Number Publication Date
JPWO2007055341A1 JPWO2007055341A1 (ja) 2009-04-30
JP5688829B2 true JP5688829B2 (ja) 2015-03-25

Family

ID=38023334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544210A Active JP5688829B2 (ja) 2005-11-11 2006-11-10 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット

Country Status (2)

Country Link
JP (1) JP5688829B2 (fr)
WO (1) WO2007055341A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR068767A1 (es) * 2007-10-12 2009-12-02 Novartis Ag Anticuerpos contra esclerostina, composiciones y metodos de uso de estos anticuerpos para tratar un trastorno patologico mediado por esclerostina
JP5717331B2 (ja) * 2008-11-07 2015-05-13 株式会社バイオマーカーサイエンス 内臓脂肪増加抑制効果の評価方法及び評価用キット、物質のスクリーニング方法、並びに、マーカーとしての使用
US20110008901A1 (en) * 2009-07-07 2011-01-13 Kiernan Urban A Apolipoprotein ciii in pre- and type 2 diabetes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002340890A (ja) * 2001-05-17 2002-11-27 Internatl Reagents Corp タンパク質の測定方法
WO2003102163A2 (fr) * 2002-06-04 2003-12-11 Metabolex, Inc. Procedes de diagnostic et de traitement du diabete et de la resistance a l'insuline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503198B1 (en) * 1997-09-11 2003-01-07 Jack L. Aronowtiz Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods
WO2006073195A1 (fr) * 2005-01-07 2006-07-13 Biomarker Science Co., Ltd Procede de prediction ou de diagnostic du diabete et kit de prediction ou diagnostic du diabete

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002340890A (ja) * 2001-05-17 2002-11-27 Internatl Reagents Corp タンパク質の測定方法
WO2003102163A2 (fr) * 2002-06-04 2003-12-11 Metabolex, Inc. Procedes de diagnostic et de traitement du diabete et de la resistance a l'insuline

Also Published As

Publication number Publication date
JPWO2007055341A1 (ja) 2009-04-30
WO2007055341A1 (fr) 2007-05-18

Similar Documents

Publication Publication Date Title
JPWO2006073195A1 (ja) 糖尿病の予知・診断方法および糖尿病予知・診断用キット
US20070292869A1 (en) Compositions and Methods for Analyzing Renal Cancer
JP5424331B2 (ja) 肝疾患診断用バイオマーカー
DK2444814T3 (en) Biomarker for mental disorders, including cognitive disorders, and method of using the biomarker for detecting mental disorders, including cognitive disorders
US20070264643A1 (en) Compositions and Methods Relating to CNS Lymphoma
WO2010032458A1 (fr) Biomarqueur inédit de la stéatose hépatique non alcoolique et méthode de détection d'une stéatose hépatique non alcoolique au moyen dudit biomarqueur
WO2015025975A1 (fr) Méthode et trousse de détection d'un début ou d'un risque de début de néphropathie diabétique
JP5688829B2 (ja) 示差的な糖尿病の予知・診断方法および糖尿病予知・診断用キット
JP2005510575A (ja) アルツハイマー病を予測するｉｇ重鎖、ｉｇカッパ、ｉｇラムダバイオポリマーマーカー
WO2006107078A1 (fr) Procede destine a evaluer l’efficacite du traitement par interferon et kit d’evaluation de celle-ci
US7135297B2 (en) Protein biopolymer markers indicative of insulin resistance
US7026129B2 (en) IG lambda biopolymer markers predictive of Alzheimers disease
JP6004369B2 (ja) 糖尿病合併症マーカーとなり得る新規ｒａｇｅリガンド
JP2005523422A (ja) インスリン耐性を予測するタンパク質バイオポリマーマーカー
JP2007278811A (ja) インターフェロン療法の有効性判定方法および判定用キットの改良
JP2005510718A (ja) Ｉｉ型糖尿病を予測する補体ｃ３前駆体バイオポリマーマーカー
JP2007291089A (ja) 成人ｔ細胞白血病マーカー
JP2005510731A (ja) Ｉｉ型糖尿病のスクリーニングのためのフィブリノゲンバイオポリマーマーカーおよびその使用
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
WO2003045991A2 (fr) Marqueurs de biopolymeres precurseurs du facteur c3 du complement permettant de predire la maladie d'alzheimer
JP2005523419A (ja) インスリン耐性を示すフィブロネクチンおよびフィブリノゲンバイオポリマーマーカー
JP2005525535A (ja) インスリン耐性を示すマクログロブリンバイオポリマーマーカー
US20030113808A1 (en) Apolipoprotein biopolymer markers predictive of alzheimers disease
US20090093000A1 (en) Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease
JP2005510725A (ja) アルツハイマー病を予測するフィブロネクチン前駆体バイオポリマーマーカー

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091021

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121102

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130926

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131016

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140627

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140630

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140813

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150123

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150126

R150 Certificate of patent or registration of utility model

Ref document number: 5688829

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350